Equities analysts expect Masimo Co. (NASDAQ:MASI) to announce $0.73 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Masimo’s earnings, with the lowest EPS estimate coming in at $0.70 and the highest estimate coming in at $0.76. Masimo posted earnings per share of $0.83 in the same quarter last year, which would suggest a negative year over year growth rate of 12%. The business is scheduled to announce its next earnings results on Wednesday, August 1st.
On average, analysts expect that Masimo will report full-year earnings of $2.88 per share for the current financial year. For the next year, analysts anticipate that the company will report earnings of $2.98 per share, with EPS estimates ranging from $2.92 to $3.03. Zacks’ EPS calculations are a mean average based on a survey of research analysts that that provide coverage for Masimo.
Get Masimo alerts:Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, May 2nd. The medical equipment provider reported $0.75 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.06. The firm had revenue of $212.90 million for the quarter, compared to analyst estimates of $205.65 million. Masimo had a net margin of 15.99% and a return on equity of 23.14%. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.57 earnings per share.
MASI has been the subject of a number of research reports. Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Monday, March 5th. ValuEngine upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research report on Monday, May 7th. Barclays initiated coverage on shares of Masimo in a research report on Friday, March 9th. They set an “overweight” rating and a $97.00 target price for the company. Piper Jaffray Companies restated a “hold” rating and set a $91.00 target price on shares of Masimo in a research report on Thursday, March 1st. Finally, BidaskClub upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, April 24th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Masimo presently has a consensus rating of “Buy” and a consensus price target of $101.17.
Shares of MASI traded up $0.14 during trading hours on Wednesday, reaching $99.12. 193,699 shares of the company traded hands, compared to its average volume of 497,507. The firm has a market capitalization of $5.13 billion, a PE ratio of 40.46, a price-to-earnings-growth ratio of 2.37 and a beta of 0.95. Masimo has a 12-month low of $80.69 and a 12-month high of $100.00.
In related news, CAO Ramshorst David J. Van sold 3,000 shares of the business’s stock in a transaction on Friday, May 4th. The shares were sold at an average price of $97.50, for a total transaction of $292,500.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,500 shares in the company, valued at $243,750. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Thursday, May 3rd. The shares were sold at an average price of $94.00, for a total transaction of $188,000.00. Following the transaction, the director now owns 62,249 shares of the company’s stock, valued at $5,851,406. The disclosure for this sale can be found here. Insiders have sold 122,303 shares of company stock valued at $11,148,690 over the last 90 days. 12.60% of the stock is currently owned by insiders.
Several institutional investors have recently modified their holdings of the business. Intrust Bank NA raised its position in shares of Masimo by 15.5% in the first quarter. Intrust Bank NA now owns 4,490 shares of the medical equipment provider’s stock worth $395,000 after acquiring an additional 603 shares during the period. Ladenburg Thalmann Financial Services Inc. raised its position in shares of Masimo by 7.4% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 10,368 shares of the medical equipment provider’s stock worth $879,000 after acquiring an additional 718 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Masimo by 39.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock worth $239,000 after acquiring an additional 802 shares during the period. Brown Capital Management LLC raised its position in shares of Masimo by 0.8% in the fourth quarter. Brown Capital Management LLC now owns 98,506 shares of the medical equipment provider’s stock worth $8,353,000 after acquiring an additional 819 shares during the period. Finally, Eagle Asset Management Inc. raised its position in shares of Masimo by 2.8% in the fourth quarter. Eagle Asset Management Inc. now owns 33,704 shares of the medical equipment provider’s stock worth $2,858,000 after acquiring an additional 932 shares during the period. Institutional investors and hedge funds own 82.92% of the company’s stock.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Get a free copy of the Zacks research report on Masimo (MASI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment